Recovery · Reference
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
This page sets out what was measured for each component and for how long, why those clocks do not combine into a GLOW timeline, and how to judge GLOW honestly on the 28-day vial it is supplied in. For the blend itself, see what is GLOW; for each claimed benefit, see GLOW benefits.
GLOW has no measured timeline, because the blend of GHK-Cu, BPC-157 and TB-500 has never been studied as a blend, in people or in animals. The time frames that exist belong to its components and to other routes: GHK-Cu creams studied on facial skin for 8 to 12 weeks, a two-week BPC-157 enema trial in ulcerative colitis, rat ligament healing followed over ninety days, and a 2026 rat Achilles study that treated daily for four weeks and found the BPC-157 and TB-500 combination did no better than either alone. None of those is a schedule for a subcutaneous injection of the three together.
This page sets out what was measured for each component and for how long, why those clocks do not combine into a GLOW timeline, and how to judge GLOW honestly on the 28-day vial it is supplied in. For the blend itself, see what is GLOW; for each claimed benefit, see GLOW benefits.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
The short answer
| Component | Study | How long it ran | What it measured | Route |
|---|---|---|---|---|
| GHK-Cu | Cosmetic-science studies in photoaged facial skin | 8 to 12 weeks | Skin density, firmness, fine lines | Topical cream |
| GHK-Cu | Wound Repair and Regeneration, 1994 | A wound-closure study | Diabetic ulcer closure | Topical gel |
| BPC-157 | Journal of Orthopaedic Research, 2010 | Ninety days | Rat knee ligament healing | Injection, drinking water or cream |
| BPC-157 | 2005 meeting abstract, 53 people with ulcerative colitis | Two weeks | Disease activity; inconclusive | Enema |
| BPC-157 and TB-500 | Joint Diseases and Related Surgery, 2026, 32 rats | Four weeks of daily treatment | Load to failure and tissue scores | Injection in rats |
| Thymosin beta-4, the parent of TB-500 | 2010 healthy-volunteer study; 2012 phase 2 in chronic ulcers | Trial periods of the full-length protein | Tolerability; ulcer healing | Intravenous; not the TB-500 fragment |
| GLOW, as a blend | None | Never studied | Nothing | Not applicable |
Read the last row first. Pepti supplies GLOW as a 5 mL vial holding 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500 for $259/mo, all-in.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
Why the component clocks do not add up to a GLOW timeline
It is tempting to take the longest component timeline, or the shortest, and call it the answer. Neither works.
| Assumption | Why it does not hold |
|---|---|
| "GLOW works on the skin in 8 to 12 weeks" | That was how long topical cream studies ran, on facial skin, with no injection involved |
| "GLOW heals tendons in four weeks" | That was a rat study, and the combination of BPC-157 and TB-500 did no better than either alone |
| "Three peptides work faster than one" | No study has compared GLOW with its components; a blend is a convenience, not a faster version of its parts |
| "The TB-500 human trials apply" | Those used full-length thymosin beta-4, intravenously; the FDA's 2026 review found no human data for TB-500 by any route |
The general how long do peptides take to work guide makes the same point for every repair peptide: tissue biology sets the pace, and stacking more peptides does not compress it.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
What was measured for each component
GHK-Cu: 50 of the 70 mg in the vial
By mass GLOW is mostly a GHK-Cu preparation. The human studies of GHK-Cu are topical: cosmetic studies of creams in photoaged facial skin over 8 to 12 weeks, mostly small and industry-funded, and a 1994 study of a topical gel in diabetic ulcers. Skin-penetration work in Inflammation Research in 2011 showed how different topical and injected exposure are. The underlying mechanism, collagen synthesis in cultured human fibroblasts, comes from a 1988 FEBS Letters paper. No study has timed injected GHK-Cu; see how long does GHK-Cu take to work for the detail.
BPC-157: rat tendons and a two-week enema trial
The BPC-157 tendon and ligament work is in rats: Journal of Orthopaedic Research papers in 2003, 2006 and 2010, the last following knee ligament healing over ninety days. The only randomised human study gave BPC-157 by enema daily for two weeks to 53 people with ulcerative colitis, was published only as a 2005 conference abstract, and was judged inadequate by the FDA. None of the human studies used a subcutaneous injection. More is in how long does BPC-157 take to work.
TB-500: mostly the parent protein
TB-500 is a synthetic seven-amino-acid fragment of thymosin beta-4, and most of the literature is on the full-length protein. A 1999 paper in the Journal of Investigative Dermatology reported faster wound closure in rats; a 2010 randomised study reported intravenous thymosin beta-4 well tolerated in healthy volunteers; and a 2012 paper reported phase 2 results in chronic pressure and venous stasis ulcers. Those used the whole protein, not the fragment in GLOW.
The one study that put two of them together
The 2026 Joint Diseases and Related Surgery paper was the first controlled study to test BPC-157, TB-500 and the combination in one experiment: 32 rats with a repaired Achilles tendon, four weeks of daily treatment. TB-500 reached statistical significance on load to failure and histology; BPC-157 trended better without reaching significance; the combination did not outperform either alone. GHK-Cu was not part of it.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
How to judge GLOW on a 28-day vial
| Detail | GLOW |
|---|---|
| Vial | 5 mL: 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500 |
| Typical directions | 0.25 mL (25 units) subcutaneously Monday through Friday mornings |
| Per dose | 2.5 mg GHK-Cu, 0.5 mg BPC-157, 0.5 mg TB-500 |
| Doses per vial | 20 |
| How long a vial lasts | About four weeks |
| Price | $259/mo, all-in |
Your physician sets your directions after reviewing your intake, and they are printed on the vial. The three are in fixed proportion, so every dose delivers the same split. GLOW dosage explains the label.
Because GLOW is prescribed for both a skin goal and a soft-tissue goal, decide which one you are measuring before the first dose:
- For skin: a photograph in the same light, distance and time of day, taken before you start.
- For a soft-tissue complaint: one specific, checkable thing, such as whether the area is sore the morning after a session, plus your physical therapist's own measures. Progressive loading has human trial evidence for tendinopathy that none of GLOW's components has.
- Change one thing at a time, and use one GHK-Cu product at a time, since GLOW alongside another GHK-Cu product doubles the copper.
- Never change the dose yourself. If you miss a dose, follow your directions.
If the goal is a single soft-tissue injury with nothing else in the picture, physicians often prefer the two-peptide BPC-157 + TB-500 ($259/mo). If inflammation is part of the picture, KLOW adds KPV; KLOW vs GLOW compares them.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
When waiting is the wrong answer
A complete rupture, a displaced fracture or a significant meniscal tear is a surgical question no peptide changes. A skin change that is new, changing or will not heal belongs with a dermatologist. Waiting longer on GLOW does not alter either.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
When to message your care team
- Nausea or light-headedness that persists.
- An injection site that stays red, hot or painful. A faint blue-green mark that clears is copper from the GHK-Cu.
- Nothing at all by the review point your physician described.
- A new symptom you did not have before starting.
A reaction that is severe or spreading, or any difficulty breathing, is an emergency: call 911, then contact your physician. Who should not take GLOW, or should discuss it first, includes anyone with Wilson's disease or another copper-metabolism disorder, a personal history of cancer, anticoagulant use, pregnancy or breastfeeding, and tested athletes, since BPC-157 and TB-500 are on the WADA Prohibited List at all times. The full list is in GLOW side effects.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
What the evidence shows, honestly
GLOW is three separate literatures in one vial, mostly animal and cell work, with small topical human studies for GHK-Cu and an incomplete enema abstract for BPC-157. The blend has never been tested, so it has no timeline, no effect size and no evidence that the three together do more than one alone.
All three components were placed in Category 2 of the FDA's interim 503A list in 2023 and removed on 15 April 2026. On 23 July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with one abstention, to recommend adding BPC-157, and by the same margin TB-500, to the 503A Bulks List; the final determination is pending. GHK-Cu is scheduled for the committee before the end of February 2027. Compounded medications are not FDA approved.
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500
Where to get GLOW prescribed
GLOW cannot be bought legitimately without a prescription. Sites selling peptide blends "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with ice packs, ready to use, with sterile syringes, alcohol prep pads and your directions printed on the vial.
- Your physician stays reachable for questions and side effects.
Pepti is cash-pay and does not bill insurance; the price covers medication, physician review, refill management and shipping, with no membership fee.
References
What this is based on.
References
- Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts · Molecules (2014) · PMID 25415472
- Krivic A, Anic T, Seiwerth S, et al.. Achilles detachment of rat and stable gastric pentadecapeptide BPC 157 · Journal of Orthopaedic Research (2006) · PMID 16583442
- Sikiric P, Seiwerth S, Rucman R, et al.. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract · Current Pharmaceutical Design (2011) · PMID 21548867
- Cerovecki T, Bojanic I, Brcic L, Radic B, et al.. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat · J Orthop Res (2010) · PMID 20225319
- Sikiric P, Seiwerth S, Rucman R, Turkovic B, et al.. Stable gastric pentadecapeptide BPC 157-NO-system relation · Curr Pharm Des (2014) · PMID 23755725
- Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H · Drug Test Anal (2017) · PMID 28035768
- Thomas A, Görgens C, Guddat S et al.. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry · J Sep Sci (2016) · PMID 26578461
- Farrar JT, Young JP Jr, LaMoreaux L, Werth JL et al.. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale · Pain (2001) · PMID 11690728
- Meyer JD, Ho B, Manning MC. Effects of conformation on the chemical stability of pharmaceutically relevant polypeptides · Pharm Biotechnol (2002) · PMID 11987755
- Xu C, Sun L, Ren F, Huang P, et al.. Preclinical Safety Evaluation of Body Protective Compound-157, a Potential Drug for Treating Various Wounds · Regul Toxicol Pharmacol (2020) · PMID 32334036
- He L, Feng D, Guo H, et al.. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs · Front Pharmacol (2022) · PMID 36588717
- Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain · Altern Ther Health Med (2021) · PMID 34324435
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
How Long Does GLOW Take to Work? What Was Measured for GHK-Cu, BPC-157 and TB-500, answered.
No study has measured it, because GLOW has never been studied as a blend. The time frames that exist belong to its components, mostly in animals or by other routes.
GHK-Cu cream studies on facial skin ran 8 to 12 weeks. A BPC-157 enema trial in ulcerative colitis ran two weeks. A rat knee ligament study followed healing over ninety days, and a 2026 rat Achilles study treated daily for four weeks.
That has not been shown. The one rat study that tested BPC-157, TB-500 and the pair found the combination did not outperform either alone at four weeks, and GLOW itself has never been compared with anything.
There is no study of injected GLOW, or of injected GHK-Cu, for skin. The 8 to 12 week figure comes from topical cream studies.
No human study has timed it. The tendon work is in rats, and rehabilitation under a physical therapist has human evidence that none of the three components has.
Until the review point your physician set, judged against a photograph or a specific measure you recorded before the first dose. A vial covers about four weeks and refills run every 28 days, one vial per fill.
KLOW contains the same 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500 plus 10 mg KPV. Both are $259 a month at Pepti. See KLOW vs GLOW.
No. Compounded medications are not FDA approved, and neither GLOW nor any of its components is approved for anything.
At Pepti, GLOW is $259 a month, all-in, covering medication, physician review, refill management and shipping.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.